| VWF |
|---|
|
| Available structures |
|---|
| PDB | Ortholog search: PDBe RCSB |
|---|
| List of PDB id codes |
|---|
1AO3, 1ATZ, 1AUQ, 1FE8, 1FNS, 1IJB, 1IJK, 1M10, 1OAK, 1U0N, 2ADF, 3GXB, 3HXO, 3HXQ, 3PPV, 3PPW, 3PPX, 3PPY, 3ZQK, 4DMU, 1UEX, 2MHP, 2MHQ, 4C29, 4C2A, 4C2B, 4NT5, 5BV8 |
|
|
| Identifiers |
|---|
| Aliases | VWF, F8VWD, von Willebrand factor |
|---|
| External IDs | OMIM: 613160; MGI: 98941; HomoloGene: 466; GeneCards: VWF; OMA:VWF - orthologs |
|---|
| Gene location (Human) |
|---|
| | Chr. | Chromosome 12 (human)[1] |
|---|
| | Band | 12p13.31 | Start | 5,948,877 bp[1] |
|---|
| End | 6,124,770 bp[1] |
|---|
|
| Gene location (Mouse) |
|---|
| | Chr. | Chromosome 6 (mouse)[2] |
|---|
| | Band | 6 F3|6 59.32 cM | Start | 125,523,737 bp[2] |
|---|
| End | 125,663,642 bp[2] |
|---|
|
| RNA expression pattern |
|---|
| Bgee | | Human | Mouse (ortholog) |
|---|
| Top expressed in | - urethra
- tendon of biceps brachii
- apex of heart
- right lung
- upper lobe of left lung
- pericardium
- left ventricle
- subcutaneous adipose tissue
- right auricle of heart
- lower lobe of lung
|
| | Top expressed in | - right lung lobe
- external carotid artery
- internal carotid artery
- umbilical cord
- tunica media of zone of aorta
- blood
- carotid body
- pineal gland
- tunica adventitia of aorta
- sciatic nerve
|
| | More reference expression data |
|
|---|
| BioGPS | |
|---|
|
| Gene ontology |
|---|
| Molecular function | | | Cellular component | | | Biological process | | | Sources:Amigo / QuickGO |
|
|
| Wikidata |
|
Von Willebrand factor (VWF) (German: [fɔn ˈvɪləbʁant]) is a blood glycoprotein that promotes primary hemostasis, specifically, platelet adhesion. It is deficient and/or defective in von Willebrand disease and is involved in many other diseases, including thrombotic thrombocytopenic purpura, Heyde's syndrome, and possibly hemolytic–uremic syndrome.[5] Increased plasma levels in many cardiovascular, neoplastic, metabolic (e.g. diabetes), and connective tissue diseases are presumed to arise from adverse changes to the endothelium, and may predict an increased risk of thrombosis.[6]
Platelet adhesion is mainly mediated via interactions with vWF, which acts as a bridge between the platelet surface receptor glycoprotein Ib (GpIb) and the exposed collagen after vascular injury. Genetic deficiencies of vWF or GpIb (Bernard-Soulier syndrome) result in bleeding disorders.[7]
- ^ a b c GRCh38: Ensembl release 89: ENSG00000110799 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000001930 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Sadler JE (1998). "Biochemistry and genetics of von Willebrand factor". Annual Review of Biochemistry. 67: 395–424. doi:10.1146/annurev.biochem.67.1.395. PMID 9759493.
- ^ Shahidi M (2017). "Thrombosis and von Willebrand Factor". Thrombosis and Embolism: From Research to Clinical Practice. Advances in Experimental Medicine and Biology. Vol. 906. pp. 285–306. doi:10.1007/5584_2016_122. ISBN 978-3-319-22107-6. PMID 27628010.
- ^ Kumar, Vinay; Abbas, Abul K.; Aster, Jon C.; Perkins, James A., eds. (2018). Robbins basic pathology (Tenth ed.). Philadelphia, Pennsylvania: Elsevier. ISBN 978-0-323-35317-5.